Will Exact Sciences Corporation (EXAS) Continue to Penetrate the Market with Its Cologuard Test?

Will Exact Sciences Corporation (EXAS) Continue to Penetrate the Market with Its Cologuard Test?

Upworthy

Published

In This Article: In its second-quarter 2025 investor letter, Baron Health Care Fund highlighted stocks such as Exact Sciences Corporation (NASDAQ:EXAS). Exact Sciences Corporation (NASDAQ:EXAS) provides cancer screening and diagnostic test products. The one-month return of Exact Sciences…

Full Article